Mersana Therapeutics Inc. (MRSN)
undefined
undefined%
At close: undefined
2.15
0.23%
After-hours Dec 13, 2024, 05:51 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 36.85M 26.58M 43.00K 828.00K 42.12M 10.59M 17.55M 25.17M 10.36M
Cost of Revenue 148.27M 927.00K 132.01M 67.04M 55.04M 59.91M 928.00K 32.01M 21.35M
Gross Profit -111.41M 25.65M -131.97M -66.21M -12.92M -49.32M 16.62M -6.84M -10.99M
Operating Income -170.96M -204.69M -169.71M -87.69M -29.22M -65.66M -39.62M -13.82M -16.34M
Interest Income 12.07M 2.88M 65.00K 424.00K 2.23M 1.40M 910.00K 121.00K 2.00K
Pretax Income -171.67M -204.21M -170.06M -88.05M -28.21M -64.26M -38.71M -13.70M -16.43M
Net Income -171.67M -207.54M -169.21M -88.40M -27.20M -64.26M -38.71M -13.70M -16.43M
Selling & General & Admin 59.54M 56.96M 36.89M 21.90M 17.28M 16.33M 10.46M 6.98M 5.35M
Research & Development 148.27M 173.38M 132.01M 67.04M 55.04M 59.91M 46.70M 32.01M 21.35M
Other Expenses - -445.00K -1.20M - - 1.40M - - -89.00K
Operating Expenses 36.85M 230.35M 168.90M 88.94M 72.32M 76.25M 57.16M 38.99M 26.70M
Interest Expense 4.07M 3.33M 1.27M 359.00K 234.00K - - - -
Selling & Marketing Expenses - - - - - - - - -
Cost & Expenses 207.81M 230.35M 168.90M 88.94M 72.32M 76.25M 57.16M 38.99M 26.70M
Income Tax - 3.33M -855.00K 359.00K -1.01M 1.40M - - -2.00K
Shares Outstanding (Basic) 116.11M 93.65M 70.58M 61.49M 43.40M 23.03M 12.02M 17.49M 17.49M
Shares Outstanding (Diluted) 116.11M 93.65M 70.58M 61.49M 43.49M 23.03M 12.02M 17.49M 17.49M
EPS (Basic) -1.48 -2.22 -2.4 -1.44 -0.63 -2.79 -3.22 -0.78 -0.94
EPS (Diluted) -1.48 -2.22 -2.4 -1.44 -0.63 -2.79 -3.22 -0.78 -0.94
EBITDA -166.08M -199.96M -167.94M -86.68M -26.73M -63.00M -37.78M -13.17M -16.04M
Depreciation & Amortization 1.52M 927.00K 855.00K 1.01M 1.25M 1.26M 928.00K 655.00K 297.00K